Veterinary Medicines

Parvoruvax, süstesuspensioon sigadele

Authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
  • Porcine parvovirus, Inactivated
Download as PDF

Product identification

Medicine name:
Parvoruvax, süstesuspensioon sigadele
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
  • Porcine parvovirus, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    dose
  • Porcine parvovirus, Inactivated
    2.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1202
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 7/04/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 27/11/2024
Download